Inspra (Eplerenone)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Inspra (Eplerenone), covering 2016-01-12 to 2024-08-16. Get the full timeline:
Most recent: Clinical Trial Update: Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patients With Structural Heart Disease [Phase 1]